JPH08510455A - １７，２０―リアーゼ阻害活性を有するカルバゾール誘導体 - Google Patents
１７，２０―リアーゼ阻害活性を有するカルバゾール誘導体Info
- Publication number
- JPH08510455A JPH08510455A JP7500181A JP50018195A JPH08510455A JP H08510455 A JPH08510455 A JP H08510455A JP 7500181 A JP7500181 A JP 7500181A JP 50018195 A JP50018195 A JP 50018195A JP H08510455 A JPH08510455 A JP H08510455A
- Authority
- JP
- Japan
- Prior art keywords
- formula
- compound
- group
- carbazole
- ylmethyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Indole Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB939310635A GB9310635D0 (en) | 1993-05-21 | 1993-05-21 | Chemical compounds |
| GB9310635.9 | 1993-05-21 | ||
| PCT/EP1994/001613 WO1994027989A1 (en) | 1993-05-21 | 1994-05-19 | Carbazole derivatives with 17,20-lyase-inhibiting activity |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JPH08510455A true JPH08510455A (ja) | 1996-11-05 |
Family
ID=10736007
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP7500181A Pending JPH08510455A (ja) | 1993-05-21 | 1994-05-19 | １７，２０―リアーゼ阻害活性を有するカルバゾール誘導体 |
Country Status (19)
| Country | Link |
|---|---|
| EP (1) | EP0699196A1 (fi) |
| JP (1) | JPH08510455A (fi) |
| CN (1) | CN1126473A (fi) |
| AU (1) | AU6928794A (fi) |
| BG (1) | BG100154A (fi) |
| CA (1) | CA2162921A1 (fi) |
| CZ (1) | CZ305195A3 (fi) |
| FI (1) | FI955587A0 (fi) |
| GB (1) | GB9310635D0 (fi) |
| HU (1) | HUT73790A (fi) |
| IL (1) | IL109703A0 (fi) |
| NO (1) | NO954681D0 (fi) |
| OA (1) | OA10195A (fi) |
| PE (1) | PE31195A1 (fi) |
| PL (1) | PL311702A1 (fi) |
| SK (1) | SK142495A3 (fi) |
| TW (1) | TW279866B (fi) |
| WO (1) | WO1994027989A1 (fi) |
| ZA (1) | ZA943494B (fi) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2016515098A (ja) * | 2013-02-27 | 2016-05-26 | ブリストル−マイヤーズ スクイブ カンパニーＢｒｉｓｔｏｌ−Ｍｙｅｒｓ Ｓｑｕｉｂｂ Ｃｏｍｐａｎｙ | ブロモドメイン阻害剤として有用なカルバゾール化合物 |
Families Citing this family (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5807880A (en) * | 1993-09-30 | 1998-09-15 | Yamanouchi Pharmaceutical Co., Ltd. | Azole derivative and pharmaceutical composition thereof |
| AU3846395A (en) * | 1994-11-07 | 1996-05-31 | Janssen Pharmaceutica N.V. | Compositions comprising carbazoles and cyclodextrins |
| EP0820989A4 (en) * | 1995-03-01 | 1998-05-06 | Yamanouchi Pharma Co Ltd | IMIDAZOLE DERIVATIVES AND MEDICINAL COMPOSITION BASED ON SAID DERIVATIVES |
| EP0974584B1 (en) * | 1997-02-21 | 2003-01-15 | Takeda Chemical Industries, Ltd. | Fused ring compounds, process for producing the same and use thereof |
| TWI306099B (en) | 2000-11-17 | 2009-02-11 | Takeda Chemical Industries Ltd | Novel imidazole derivatives, production method thereof and use thereof |
| CA2429437A1 (en) | 2000-11-20 | 2002-05-23 | Takeda Chemical Industries, Ltd. | Imidazole derivatives, process for their preparation and their use |
| WO2002046186A1 (fr) | 2000-12-08 | 2002-06-13 | Takeda Chemical Industries, Ltd. | Dérivés thiazole substitués porteurs de groupes 3-pyridyl, procédé d'élaboration et leur utilisation |
| CA2612723A1 (en) * | 2005-06-24 | 2007-01-04 | Eli Lilly And Company | Tetrahydrocarbazole derivatives useful as androgen receptor modulators |
| US8093279B2 (en) | 2005-12-13 | 2012-01-10 | Gillian Reed, legal representative | Compound |
| GB0525323D0 (en) * | 2005-12-13 | 2006-01-18 | Sterix Ltd | Compound |
| CN100586932C (zh) * | 2007-01-26 | 2010-02-03 | 中国医学科学院医药生物技术研究所 | 抗肿瘤化合物及其制备方法 |
| GEP20156250B (en) | 2009-06-26 | 2015-02-25 | Novartis Ag | 1,3-disubstituted imidazolidin-2-one derivatives as inhibitors of cyp 17 |
| BR112012019551A2 (pt) * | 2010-02-04 | 2016-08-09 | Radius Health Inc | moduladores seletivos do receptor de androgênio. |
| CA2799183A1 (en) | 2010-05-12 | 2011-11-17 | Radius Health, Inc. | Therapeutic regimens |
| JP5998137B2 (ja) | 2010-08-04 | 2016-09-28 | ペルフィキュア ファーマシューティカルズ，インコーポレイテッド | 前立腺癌を処置するための併用療法 |
| WO2012035078A1 (en) | 2010-09-16 | 2012-03-22 | Novartis Ag | 17α-HYDROXYLASE/C17,20-LYASE INHIBITORS |
| JP5965909B2 (ja) | 2010-09-28 | 2016-08-10 | ラジウス ヘルス，インコーポレイテッド | 選択的アンドロゲン受容体モジュレーター |
| EA023064B1 (ru) | 2011-04-28 | 2016-04-29 | Новартис Аг | ИНГИБИТОРЫ 17α-ГИДРОКСИЛАЗЫ/C-ЛИАЗЫ |
| WO2014158875A1 (en) | 2013-03-14 | 2014-10-02 | Pellficure Pharmaceuticals Inc. | Novel therapy for prostate carcinoma |
| US9421264B2 (en) | 2014-03-28 | 2016-08-23 | Duke University | Method of treating cancer using selective estrogen receptor modulators |
| HUE061499T2 (hu) | 2014-03-28 | 2023-07-28 | Univ Duke | Mellrák kezelése szelektív ösztrogénreceptor-módosítók alkalmazásával |
| EP3191087A1 (en) | 2014-09-12 | 2017-07-19 | Pellficure Pharmaceuticals, Inc. | Compositions and methods for treatment of prostate carcinoma |
| AU2017281038B2 (en) | 2016-06-22 | 2021-09-09 | Ellipses Pharma Ltd | AR+ breast cancer treatment methods |
| EP3528799A1 (en) | 2016-10-24 | 2019-08-28 | Pellficure Pharmaceuticals, Inc. | Pharmaceutical compositions of 5-hydroxy-2-methylnaphthalene-1, 4-dione |
| KR20230109795A (ko) | 2017-01-05 | 2023-07-20 | 래디어스 파마슈티컬스, 인코포레이티드 | Rad1901-2hcl의 다형 형태 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CS229934B2 (en) * | 1981-07-07 | 1984-07-16 | Pfizer | Production method subst.indolylacryte acid derivative |
| GB8518743D0 (en) * | 1985-07-24 | 1985-08-29 | Glaxo Group Ltd | Heterocyclic compounds |
-
1993
- 1993-05-21 GB GB939310635A patent/GB9310635D0/en active Pending
-
1994
- 1994-05-02 ZA ZA943494A patent/ZA943494B/xx unknown
- 1994-05-17 TW TW083104441A patent/TW279866B/zh active
- 1994-05-19 AU AU69287/94A patent/AU6928794A/en not_active Abandoned
- 1994-05-19 CA CA002162921A patent/CA2162921A1/en not_active Abandoned
- 1994-05-19 CZ CZ953051A patent/CZ305195A3/cs unknown
- 1994-05-19 HU HU9503321A patent/HUT73790A/hu unknown
- 1994-05-19 EP EP94917647A patent/EP0699196A1/en not_active Withdrawn
- 1994-05-19 JP JP7500181A patent/JPH08510455A/ja active Pending
- 1994-05-19 SK SK1424-95A patent/SK142495A3/sk unknown
- 1994-05-19 WO PCT/EP1994/001613 patent/WO1994027989A1/en not_active Application Discontinuation
- 1994-05-19 CN CN94192683A patent/CN1126473A/zh active Pending
- 1994-05-19 PL PL94311702A patent/PL311702A1/xx unknown
- 1994-05-20 IL IL10970394A patent/IL109703A0/xx unknown
- 1994-11-18 PE PE1994255110A patent/PE31195A1/es not_active Application Discontinuation
-
1995
- 1995-11-17 OA OA60742A patent/OA10195A/en unknown
- 1995-11-20 FI FI955587A patent/FI955587A0/fi not_active Application Discontinuation
- 1995-11-20 NO NO954681A patent/NO954681D0/no unknown
- 1995-11-21 BG BG100154A patent/BG100154A/xx unknown
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2016515098A (ja) * | 2013-02-27 | 2016-05-26 | ブリストル−マイヤーズ スクイブ カンパニーＢｒｉｓｔｏｌ−Ｍｙｅｒｓ Ｓｑｕｉｂｂ Ｃｏｍｐａｎｙ | ブロモドメイン阻害剤として有用なカルバゾール化合物 |
Also Published As
| Publication number | Publication date |
|---|---|
| BG100154A (en) | 1996-07-31 |
| GB9310635D0 (en) | 1993-07-07 |
| TW279866B (fi) | 1996-07-01 |
| PL311702A1 (en) | 1996-03-04 |
| HUT73790A (en) | 1996-09-30 |
| CA2162921A1 (en) | 1994-12-08 |
| EP0699196A1 (en) | 1996-03-06 |
| CZ305195A3 (en) | 1996-06-12 |
| IL109703A0 (en) | 1994-08-26 |
| FI955587A (fi) | 1995-11-20 |
| OA10195A (en) | 1996-12-18 |
| SK142495A3 (en) | 1996-06-05 |
| PE31195A1 (es) | 1995-10-18 |
| ZA943494B (en) | 1995-01-23 |
| CN1126473A (zh) | 1996-07-10 |
| HU9503321D0 (en) | 1996-01-29 |
| FI955587A0 (fi) | 1995-11-20 |
| WO1994027989A1 (en) | 1994-12-08 |
| NO954681L (no) | 1995-11-20 |
| AU6928794A (en) | 1994-12-20 |
| NO954681D0 (no) | 1995-11-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JPH08510455A (ja) | １７，２０―リアーゼ阻害活性を有するカルバゾール誘導体 | |
| SU1574178A3 (ru) | Способ получени производных 4-замещенного андростендиона, или их фармацевтически приемлемых солей | |
| AU780989B2 (en) | 3alpha-hydroxy-3beta methoxymethyl-21-heterocycle substituted steroids with anesthetic activity | |
| JPS6383095A (ja) | ４−置換６−アルキリデンアンドロステン−３，１７−ジオン誘導体およびその製造方法 | |
| US5578630A (en) | Heterocyclic compounds which inhibit aromatase | |
| NO300497B1 (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive benzazepin-forbindelser | |
| WO1997026242A1 (fr) | Derives de 3-(bis-phenylmethylene substitue) oxindole | |
| JP4909889B2 (ja) | ２ｈ−又は３ｈ−ベンゾ［ｅ］インダゾール１−イルカルバメート誘導体、これらの調製及び治療的使用 | |
| US6689798B2 (en) | Benzofuran derivatives | |
| EP0812322A1 (en) | PYRIMIDO 4,5-b]INDOLES | |
| JPH0291074A (ja) | 置換された５，６，７，８‐テトラヒドロイミダゾ［１，５‐ａ］ピリジン及びその製造方法 | |
| NO132201B (fi) | ||
| NO174928B (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive enoletere av 6-klor-4-hydroksy-2-metyl-N-(2-pyridyl)-2H-tieno(2,3-e)-1,2-tiazin-3-karboksylsyreamid-1,1-dioksyd | |
| JPS63101397A (ja) | １，２β−メチレン−４−置換アンドロステン−３，１７−ジオン誘導体およびその製造方法 | |
| JP3252189B2 (ja) | ピラゾロ〔１，５−ａ〕ピリミジン誘導体 | |
| US5726196A (en) | Aromatase-inhibiting composition containing azole derivative | |
| EP0574992A1 (en) | 5-(1,2,4-Triazol-1-ylmethyl)-3H-isobenzofuran-1-one derivatives, their preparation and use as aromatase inhibitors | |
| WO1991011434A1 (fr) | Derive de bicyclolactame | |
| HRP940940A2 (en) | Chemical compounds | |
| NO115111B (fi) | ||
| JPH01121274A (ja) | ２−置換シクロヘプトイミダゾール誘導体、抗潰瘍剤並びにその製法 | |
| JPH0278681A (ja) | 新規アルカロイドおよび該アルカロイドを有効成分とする降圧剤 | |
| JPS58146568A (ja) | 新規なジベンズアゼピン−２−酢酸誘導体 | |
| JPS6061568A (ja) | 新規な１位置換アミン誘導体 | |
| JPH10120632A (ja) | Ｎ−シクロアルキル−〔ω−（３，４−ジヒドロ−２−ナフタレニル）アルキル〕アミン誘導体及びそれを含有する医薬組成物 |